The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Other findings included: Gallbladder issues (especially with rapid weight loss) Pancreatitis (rare, with unclear causality) Thyroid C-cell hyperplasia (in animals, not seen in humans) Lean mass lossup to 40% of weight lost may be muscle in older adults None of these derailed regulatory approvals
Here is the exact procedure, assuming you are using a standard U-100 insulin syringe
By pairing tirzepatide with B12 , the goal shifts from simply losing weight to creating a more energetic, resilient you
Who is Methylcobalamin for